View in EDS PDF Full Text

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.

Saved in:
Bibliographic Details
Title: Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Authors: Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Anker SD; Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité-Universitätsmedizin, Berlin, Germany., Filippatos G; School of Medicine, National and Kapodistrian University of Athens, Department of Cardiology, Attikon University Hospital, Athens, Greece., Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI., Ruilope LM; Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research Imas12, Madrid, Spain.; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain., Birkenfeld AL; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.; Department of Internal Medicine, Division of Diabetology, Endocrinology, and Nephrology, and Institute of Diabetes Research and Metabolic Diseases (IDM), Helmholtz Center Munich and University Hospital Tübingen, Tübingen, Germany., McGill JB; Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, St. Louis, MO., Rosas SE; Kidney and Hypertension Unit, Joslin Diabetes Center and Harvard Medical School, Boston, MA.; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA., Joseph A; Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany., Gebel M; Statistics and Data Insights, Bayer AG, Wuppertal, Germany., Roberts L; Clinical Development, Bayer PLC, Reading, U.K., Scheerer MF; Medical Affairs and Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany., Bakris GL; Department of Medicine, University of Chicago Medicine, Chicago, IL., Agarwal R; Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, IN.
Corporate Authors: FIDELIO-DKD and FIGARO-DKD Investigators
Source: Diabetes care [Diabetes Care] 2022 Dec 01; Vol. 45 (12), pp. 2991-2998.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35972218
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rossing+P%22">Rossing P</searchLink>; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Anker+SD%22">Anker SD</searchLink>; Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité-Universitätsmedizin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Filippatos+G%22">Filippatos G</searchLink>; School of Medicine, National and Kapodistrian University of Athens, Department of Cardiology, Attikon University Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Pitt+B%22">Pitt B</searchLink>; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Ruilope+LM%22">Ruilope LM</searchLink>; Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research Imas12, Madrid, Spain.; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Birkenfeld+AL%22">Birkenfeld AL</searchLink>; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.; Department of Internal Medicine, Division of Diabetology, Endocrinology, and Nephrology, and Institute of Diabetes Research and Metabolic Diseases (IDM), Helmholtz Center Munich and University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22McGill+JB%22">McGill JB</searchLink>; Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, St. Louis, MO.<br /><searchLink fieldCode="AU" term="%22Rosas+SE%22">Rosas SE</searchLink>; Kidney and Hypertension Unit, Joslin Diabetes Center and Harvard Medical School, Boston, MA.; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Joseph+A%22">Joseph A</searchLink>; Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Gebel+M%22">Gebel M</searchLink>; Statistics and Data Insights, Bayer AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Roberts+L%22">Roberts L</searchLink>; Clinical Development, Bayer PLC, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Scheerer+MF%22">Scheerer MF</searchLink>; Medical Affairs and Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bakris+GL%22">Bakris GL</searchLink>; Department of Medicine, University of Chicago Medicine, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Agarwal+R%22">Agarwal R</searchLink>; Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, IN.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22FIDELIO-DKD+and+FIGARO-DKD+Investigators%22">FIDELIO-DKD and FIGARO-DKD Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227805975%22">Diabetes care</searchLink> [Diabetes Care] 2022 Dec 01; Vol. 45 (12), pp. 2991-2998.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7805975 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-5548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201495992%22">01495992 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Care <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35972218
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2337/dc22-0294
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2991
    Titles:
      – TitleFull: Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rossing P
      – PersonEntity:
          Name:
            NameFull: Anker SD
      – PersonEntity:
          Name:
            NameFull: Filippatos G
      – PersonEntity:
          Name:
            NameFull: Pitt B
      – PersonEntity:
          Name:
            NameFull: Ruilope LM
      – PersonEntity:
          Name:
            NameFull: Birkenfeld AL
      – PersonEntity:
          Name:
            NameFull: McGill JB
      – PersonEntity:
          Name:
            NameFull: Rosas SE
      – PersonEntity:
          Name:
            NameFull: Joseph A
      – PersonEntity:
          Name:
            NameFull: Gebel M
      – PersonEntity:
          Name:
            NameFull: Roberts L
      – PersonEntity:
          Name:
            NameFull: Scheerer MF
      – PersonEntity:
          Name:
            NameFull: Bakris GL
      – PersonEntity:
          Name:
            NameFull: Agarwal R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2022 Dec 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1935-5548
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Diabetes care
              Type: main
ResultId 1